Skip to content

Normal Values of Brain Natriuretic Peptide in Healthy Newborn

Normal Values of Brain Natriuretic Peptide in Healthy Newborn

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02574806
Enrollment
167
Registered
2015-10-14
Start date
2014-04-30
Completion date
2015-04-30
Last updated
2018-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reference Values of BNP in Healthy Newborn

Keywords

BNP, Reference values, Newborn, Ventricular function, Stress, Pediatrics, Biomarkers

Brief summary

Brain natriuretic peptide (BNP) is an important tool for diagnosis, risk stratification and prognosis in pediatric patients with heart failure1. In newborn, after delivery, the BNP plays an important role in cardiopulmonary hemodynamics by stimulating vasodilatation and diuresis. The gradual decrease in pulmonary pressure and the initiation of diuresis as expression of renal maturity could explain the subsequent decrease in serum values. This would suggest that, in healthy newborns, BNP values should be found within a given ranges. However, the evidence suggests an important variability in BNP values 2 - 4. In the other hand, in the newborn with respiratory distress BNP could have a high negative predictive value to rule out acute myocardial processes, as responsible for clinical deterioration, from infectious, metabolic or respiratory processes; with a potential of improvement in medical care. Even the increased use of this biomarker in clinical practice, until our knowledge, BNP normal values remain unknown in the healthy newborn. Therefore, the investigators performed a pioneer study to establish normal values in healthy newborn population. Multi-center, prospective and observational study was carried out. Objective: To establish normal BNP values in healthy newborn.

Interventions

PROCEDUREBlood sample and BNP measurement

Blood sample of umbilical artery from umbilical cord immediately after birth.

Sponsors

Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Minutes
Healthy volunteers
Yes

Inclusion criteria

* healthy mother with pregnancy at term (38 to 42 gestational weeks) with adequate prenatal care. * newborns with Apgar score ≥ 7 at 0 and 5 minutes respectively.

Exclusion criteria

* newborns of mothers with pregnancy-associated diseases. * newborns with chromosomopathies detected during the antenatal care and newborns with signs of cardiac and/or respiratory compromise.

Design outcomes

Primary

MeasureTime frame
BNP valueswithin the first minute after birth and data will present through study completion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026